BioPharm America™ 2014 returns to Boston’s Copley Place and a celebration of the FierceBiotech Fierce 15

The seventh annual BioPharm America™ international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston’s historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic collaborations with leading companies.

Pharmaceutical companies typically send teams of senior executives to meet with potential partners from biotech companies, academic institutions and service providers. AstraZeneca, Bayer HealthCare, Bristol-Myers Squibb, EMD Serono, Novo Nordisk, and Shire are just a few large drug developers set to attend.

BioPharm America is our largest North American life science partnering event, well-known for its reputable one-to-one partnering formula,” said Florian Schoenhammer, Group Managing Director of EBD Group. “Not only does it tap into the incredible amount of biotech innovation in Boston, as recognized by global pharmaceutical companies and investors, but the event is a catalyst for early stage dealmaking that is the mainstay of the drug development industry.”

“We are proud to host BioPharm America again in Boston,” said Robert Coughlin, President and CEO of MassBio. “This is a high caliber event that capitalizes on the full range of industry innovation available in Boston. And there is a wide range of partners who attend, from small start-ups to mid-size biotech companies, service providers and international pharma. Companies can tie up their partnering strategies for the year in just a couple days. There is no other industry gathering quite like it.”

BioPharm America 2014 will again celebrate the announcement of the annual FierceBiotechFierce 15. The Fierce 15 is a hunt that involves the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential to have a huge impact on the treatment of human diseases. John Carroll, Editor-in-Chief ofFierceBiotech, will announce the winners at the event and will lead a panel with several Fierce 15 CEOs to discuss the industry outlook going into the fourth quarter 2014.

More than 900 delegates representing 550 companies from 35 countries participated in BioPharm America 2013. Delegates in 2013 engaged in 2,950 one-to-one partnering meetings and identified 757 potential licensing opportunities.

One-to-one networking at BioPharm America™ is powered by partneringONE®, the leading conference networking solution for the life sciences.

Register before July 18, 2014 to save USD 200. MassBio members receive an additional USD 200 discount by adding the code ‘MassBio‘ in the comments field of the online registration form.

Presenting companies should submit an application by June 30, 2014.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About BioPharm America 2014

BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

Additional links and information:

Follow BioPharm America 2014 on Twitter: (hashtag: #BPA14)

Or join the Life Science Partnering group on partnering360® to kick off your partnering activities before BioPharm America, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of life science companies on partnerning360 today.